Delivery Order 36C25624D0098-36C25626N0705

Veterans Integrated Service Network 16 issued a purchase order to Veracyte, Inc. for genomic testing valued at $405,018, awarded June 1, 2024, with performance completion by May 31, 2029. The order is firm fixed price with no small business set-aside. Work is performed in Shreveport, Louisiana. The procurement incorporates diversity, equity, and inclusion objectives through Executive Order 14398. Veracyte delivers proprietary molecular diagnostic testing services, including thyroid nodule...

The Department of Veterans Affairs, Veterans Integrated Service Network 16 (VISN 16) awarded a definitive firm fixed-price contract to Veracyte, Inc. on December 14, 2020 for laboratory sample testing services with a ceiling value of $314,712.55 and an ultimate completion date of June 30, 2026. The work will be performed in North Little Rock, Arkansas. This award was not set aside for any socioeconomic designation and represents Veracyte's continued engagement with the VA to deliver...

Veterans Integrated Service Network 5 issued a delivery order to Veracyte, Inc. on March 23, 2026, with a ceiling value of $412,750 for molecular testing services, under a firm fixed-price arrangement. Place of performance is Baltimore, MD. The order extends through March 22, 2031. Veracyte specializes in advanced genomic diagnostic testing for precision medicine applications, including proprietary molecular tests for prostate cancer risk assessment, thyroid nodule malignancy stratification, and...

Veterans Integrated Service Network 8 issued a $248,650 delivery order to Veracyte, Inc. on July 16, 2026, for the Afirma Genomic Sequencing Classifier, a proprietary molecular diagnostic test for thyroid nodule assessment and malignancy risk stratification. The order is placed under the GSA Medical Laboratory Testing and Analysis Services Federal Supply Schedule (FSS-621-II). Place of performance is Bay Pines, FL. The order carries a firm fixed-price structure with an ultimate completion date...

<p>Veterans Integrated Service Network 23 issued a $45,000 delivery order to Veracyte, Inc. on May 1, 2025, for reference laboratory services under a parent IDIQ with a ceiling of $2 million through April 30, 2028.</p> <p>Place of performance is South San Francisco, CA. The delivery order is priced on a firm fixed-price basis with no set-aside. The order is ultimate completion date is April 30, 2026.</p>

Veterans Integrated Service Network 23 issued a $47,600 delivery order to Veracyte, Inc. on May 1, 2025, under the Veracyte Reference Laboratory Services IDIQ for reference laboratory testing services. The parent IDIQ, effective May 1, 2023 through April 30, 2028, carries a $2 million ceiling and supports Veracyte's provision of specialty genomic testing and molecular diagnostic services to the VA healthcare system. Place of performance is South San Francisco, CA. This delivery order, priced...

The Department of Veterans Affairs, Veterans Integrated Service Network 23 (VISN 23), awarded a $67.6K delivery order to Veracyte, Inc. on May 1, 2026, for reference laboratory and genomic testing services supporting the NWI-Omaha VA facility. The order is structured as a firm fixed-price delivery order with a completion deadline of September 30, 2026, and carries no small business set-aside designation. This award is issued under Veracyte's existing $2M indefinite delivery/indefinite quantity...

This firm fixed-price purchase order was awarded by the Department of Veterans Affairs to Veracyte, Inc., a for-profit provider of genomic testing services. The $136,469.48 contract provides Thyroid Fine Needle Aspiration (AFIRMA) genetic classifier testing services to support cancer detection efforts at the G.V. (Sonny) Montgomery VA Medical Center in Jackson, MS. This order was issued under an existing Indefinite Delivery Indefinite Quantity (IDIQ) contract between Veracyte and the VA's...

This is a firm fixed price purchase order contract awarded by the U.S. Army Medical Command (MEDCOM) to Veracyte, Inc., a for-profit corporation that provides genomic testing services. The contract, valued at $98,266.14, is for AFIRMA GSC TESTING services. This appears to be part of a larger Indefinite Delivery Indefinite Quantity (IDIQ) contract vehicle from the Veterans Health Administration's Veterans Integrated Service Network 23 (VISN 23), valued at up to $600,000 through April 2028, that...

This firm fixed-price purchase order for $77,700 was awarded by the Veterans Integrated Service Network 8 (VISN 8) of the U.S. Department of Veterans Affairs to Veracyte, Inc., a for-profit provider of genomic testing services. The contract is for Afirma Gene Expression Classifier and Atlas Expression Classifier testing, which analyze gene expression patterns in thyroid biopsy samples to determine malignancy risk and aid in diagnosis and treatment decisions for veterans. This award is not set...